期刊文献+

胰管支架预防内镜逆行胰胆管造影术后胰腺炎及高淀粉酶血症分析 被引量:6

原文传递
导出
摘要 目的探讨内镜下胰管支架置入预防内镜逆行胰胆管造影术(ERCP)后胰腺炎及高淀粉酶血症的效果。方法入选90例ERCP或ERCP+内镜下十二指肠乳头切开术(EST)患者。其中50例术后置入胰管支架引流(支架组),与40例非引流患者(对照组)观察比较,观察术后3h及24h血清淀粉酶值、高淀粉酶血症和术后急性胰腺炎发生率。结果支架组患者术后3h及24h血清淀粉酶值分别为(198.33±70.15)U/L、(267.54±76.34)U/L,低于对照组的(357.28±101.37)U/L、(439.72±97.13)U/L,差异有统计学意义(P〈0.05)。高淀粉酶血症发生率分别为8.00%和25.00%,差异有统计学意义(P〈0.05),术后胰腺炎发生率分别为O与10%,差异有统计学意义(P〈0.05)。结论内镜下胰管支架置入能有效预防ERCP后胰腺炎及高淀粉酶血症。
出处 《中国综合临床》 2009年第12期1286-1287,共2页 Clinical Medicine of China
  • 相关文献

参考文献8

  • 1Cotton PB, Lehman G, Vennes J, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus [J]. Gastrointest Endosc, 1991,37 ( 3 ) :383-393.
  • 2Prat F, Amaris J, Ducot B, et al. Nifedipine for prevention of post- ERCP pancreatitis: a prospective, double-blind randomized study [J]. Gastrointest Endosc ,2002,56 ( 2 ) :202-208.
  • 3Sofuni A, Maguchi H, hoi T, et al. Prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis by an endoscopic pancreatic spontaneous dislodgement stent [ J ]. Clin Gastroenterol Hepato1,2007,5 ( 11 ) : 1339-1346.
  • 4Goldberg E, Titus M, Haluszka O, et al. Pancreatic-duct stent placement facilitates difficult common bile duct carmulation[ J]. Gastreintest Endosc,2005,62(g) :592-596.
  • 5Fazel A, Quadri A, Catalano MF,et al. Does a pancreatic duct stent prevent post-ERCP pancreatitis? A prospective randomized study [ J ]. Gastrointest Endosc ,2003,57 ( 3 ) :291-294.
  • 6Cheng CL, Sherman S, Watkins JL, et al. Risk factors for post-ERCP pancreatitis: a prospective muhicenter study [ J ]. Am J Gastro- entero1,2006,101 ( 1 ) : 139-147.
  • 7束庆文.内镜下逆行胰胆管造影技术的临床应用[J].中国医药,2009,4(7):499-500. 被引量:7
  • 8袁文明,李静,徐琳,张小利.糖皮质激素预防ERCP术后胰腺炎的Meta分析[J].解放军医学杂志,2007,32(8):805-807. 被引量:8

二级参考文献14

  • 1De Palma GD,Catanzano C.Use of corticosteriods in the prevention of post-ERCP pancreatitis:results of a controlled prospective study.Am J Gastroenterol,1999,94(4):982
  • 2Budzynska A,Marek T,Nowak A,et al.A prospective,randomized,placebo-controlled trial of prednisone and allopurinol in the prevention of ERCP-induced pancreatitis.Endoscopy,2001,33(9),766
  • 3Manolakopoulos S,Avgerinos A,Vlachogiannakos J,et al.Octreotide versus hydrocortisone versus placebo in the prevention of post-ERCP pancreatitis:a multicenter randomized controlled trial.Gastrointest Endosc,2002,55(4):470
  • 4Sherman S,Blaut U,Watkins JL,et al.Does prophylactic administration of corticosteroid reduce the risk and severity of post-ERCP pancreatitis:a randomized,prospective,multicenter study.Gastro-intest Endosc,2003,58(1):23
  • 5Kwanngern K,Tiyapattanaputi P,Wanitpukdeedecha M,et al.Can a single dose corticosteroid reduce the incidence of post-ERCP pancreatitis? A randomized,prospective control study.J Med Associ Thailand,2005,88(Suppl 4):S42
  • 6Weiner GR,Geenen JE,Hogan WJ,et al.Use of corticosteroids in the prevention of post-ERCP pancreatitis.Gastrointest Endosc,1995,42(6):579
  • 7Bettinger JR,Grendell JH.Intracellular events in the pathogenesis of acute pancreatitis.Pancreas,1991,6(suppl 1):S2
  • 8Tramèr MR,von Elm E,Loubeyre P,et al.Pharmacological prevention of serious anaphylactic reactions due to iodinated contrast media:systematic review.BMJ,2006,333(7570):675
  • 9Juni P,Altman DG,Egger M.Systematic reviews in health care:Assessing the quality of controlled clinical trials.BMJ,2001,323(7303):42
  • 10Fergusson D,Aaron SD,Guyatt G,et al.Post-randomisation exclusions:the intention to treat principle and excluding patients from analysis.BMJ,2002,325(7365):652

共引文献13

同被引文献68

引证文献6

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部